Jacqueline Palace

Summary

Affiliation: University of Oxford
Country: UK

Publications

  1. doi request reprint Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
    Joanna Kitley
    Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK
    J Neurol Neurosurg Psychiatry 84:918-21. 2013
  2. doi request reprint DOK7 congenital myasthenic syndrome
    Jacqueline Palace
    Clinical Neurology, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, United Kingdom
    Ann N Y Acad Sci 1275:49-53. 2012
  3. pmc Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution
    Lucy Matthews
    Nuffield Department of Clinical Neurosciences, University of Oxford, UK
    Neurology 80:1330-7. 2013
  4. doi request reprint Identification of DPAGT1 as a new gene in which mutations cause a congenital myasthenic syndrome
    Katsiaryna Belaya
    Neurosciences Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom
    Ann N Y Acad Sci 1275:29-35. 2012
  5. doi request reprint Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype
    Joanna Kitley
    Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK
    Neurology 79:1273-7. 2012
  6. doi request reprint The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis
    Rose Gelineau-Morel
    Oxford Centre for Functional MRI of the Brain, Nuffield Department of Clinical Neurosciences, University of Oxford, United Kingdom
    Hum Brain Mapp 33:2802-14. 2012
  7. doi request reprint Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan
    Joanna Kitley
    Nuffield Department of Clinical Neurosciences, West Wing, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK
    Brain 135:1834-49. 2012
  8. doi request reprint Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride
    Tarunya Arun
    Division of Clinical Neurology, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK
    Brain 136:106-15. 2013
  9. pmc Mutations in DPAGT1 cause a limb-girdle congenital myasthenic syndrome with tubular aggregates
    Katsiaryna Belaya
    Neurosciences Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, University of Oxford, UK
    Am J Hum Genet 91:193-201. 2012
  10. pmc Relating brain damage to brain plasticity in patients with multiple sclerosis
    Valentina Tomassini
    Oxford Centre for Functional MRI of the Brain FMRIB, University of Oxford, Oxford, UK
    Neurorehabil Neural Repair 26:581-93. 2012

Collaborators

Detail Information

Publications16

  1. doi request reprint Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
    Joanna Kitley
    Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK
    J Neurol Neurosurg Psychiatry 84:918-21. 2013
    ..Immunosuppression is the mainstay of treatment but many patients do not tolerate first-line immunosuppressive agents, or experience ongoing relapses...
  2. doi request reprint DOK7 congenital myasthenic syndrome
    Jacqueline Palace
    Clinical Neurology, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, United Kingdom
    Ann N Y Acad Sci 1275:49-53. 2012
    ..Worsening in adulthood is common, particularly affecting bulbar and respiratory function. Treatment with ephedrine or oral salbutamol can result in a slow, steady, and often dramatic improvement over months...
  3. pmc Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution
    Lucy Matthews
    Nuffield Department of Clinical Neurosciences, University of Oxford, UK
    Neurology 80:1330-7. 2013
    ..Using a quantitative lesion mapping approach, this research aimed to identify differences in MRI brain lesion distribution between aquaporin-4 antibody-positive NMOSD and RRMS, and to test their diagnostic potential...
  4. doi request reprint Identification of DPAGT1 as a new gene in which mutations cause a congenital myasthenic syndrome
    Katsiaryna Belaya
    Neurosciences Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom
    Ann N Y Acad Sci 1275:29-35. 2012
    ..This finding demonstrates that impairment of the N-linked glycosylation pathway can lead to the development of CMS...
  5. doi request reprint Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype
    Joanna Kitley
    Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK
    Neurology 79:1273-7. 2012
    ..To report an association of myelin-oligodendrocyte glycoprotein (MOG) antibodies with aquaporin-4 (AQP4) antibody-seronegative neuromyelitis optica (NMO) and neuromyelitis optica spectrum disorder (NMOSD) in adults...
  6. doi request reprint The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis
    Rose Gelineau-Morel
    Oxford Centre for Functional MRI of the Brain, Nuffield Department of Clinical Neurosciences, University of Oxford, United Kingdom
    Hum Brain Mapp 33:2802-14. 2012
    ..Volumetric or morphometric imaging studies, where lesion amount and characteristics may vary between groups of patients or change over time, may especially benefit from this correction...
  7. doi request reprint Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan
    Joanna Kitley
    Nuffield Department of Clinical Neurosciences, West Wing, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK
    Brain 135:1834-49. 2012
    ..These factors need to be explored further in future prospective neuromyelitis optica and neuromyelitis optica spectrum disorder studies...
  8. doi request reprint Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride
    Tarunya Arun
    Division of Clinical Neurology, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK
    Brain 136:106-15. 2013
    ..This pilot study is the first translational study on neuroprotection targeting ASIC1 and supports future randomized controlled trials measuring neuroprotection with amiloride in patients with multiple sclerosis...
  9. pmc Mutations in DPAGT1 cause a limb-girdle congenital myasthenic syndrome with tubular aggregates
    Katsiaryna Belaya
    Neurosciences Group, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, University of Oxford, UK
    Am J Hum Genet 91:193-201. 2012
    ....
  10. pmc Relating brain damage to brain plasticity in patients with multiple sclerosis
    Valentina Tomassini
    Oxford Centre for Functional MRI of the Brain FMRIB, University of Oxford, Oxford, UK
    Neurorehabil Neural Repair 26:581-93. 2012
    ..However, functional impairments can be reduced with practice, suggesting that brain plasticity is preserved even in patients with substantial damage...
  11. doi request reprint Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete?
    Jonathan James Downer
    Department of Neuroradiology, John Radcliffe Hospital, West Wing, Level 1, OX3 9DU, Oxford, UK
    Neuroradiology 54:279-85. 2012
    ..It is part of a spectrum of neurological conditions associated with antibodies to aquaporin-4 (AQP4). This study investigates the role of MRI where novel, more sensitive AQP4 antibody immunoassay techniques are being used...
  12. doi request reprint Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers
    Jacqueline Palace
    DM, Department of Clinical Neurology, John Radcliffe Hospital, University of Oxford, Level 3 West Wing, Oxford OX3 9DU, England
    Arch Neurol 67:1016-7. 2010
    ..To describe a patient with neuromyelitis optica (NMO) whose aquaporin 4 (AQP4) antibody levels increased following treatment with interferon beta...
  13. doi request reprint Congenital myasthenic syndromes and the formation of the neuromuscular junction
    David Beeson
    Neurosciences Group, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK
    Ann N Y Acad Sci 1132:99-103. 2008
    ....
  14. doi request reprint Clinical features in a series of fast channel congenital myasthenia syndrome
    Jacqueline Palace
    Department of Neurology, John Radcliffe Hospital, Oxford, UK
    Neuromuscul Disord 22:112-7. 2012
    ..Referral to a specialist paediatric respiratory centre and regular resuscitation training for parents are recommended...
  15. doi request reprint Autoantibodies to glutamic acid decarboxylase in patients with epilepsy are associated with low cortical GABA levels
    Charlotte J Stagg
    Centre for Functional Magnetic Resonance of the Brain FMRIB, University of Oxford, Oxford, United Kingdom
    Epilepsia 51:1898-901. 2010
    ....